Research Reports
Povidone iodine market surpass US$ 256.7 Bn by 2030
Povidone iodine market surpass US$ 256.7 Bn by 2030
Published by TMR Research Insights
Posted on August 17, 2021
Global Banking and Finance Review
Company
Published by TMR Research Insights
Posted on August 17, 2021
The COVID-19 (coronavirus) continues to register new cases worldwide. Hence, companies in the povidone iodine market are increasing their R&D efforts to evaluate the efficacy of PVP-I against the novel coronavirus. For instance, global leader of consumer health products, Avrio Health L.P., has initiated a program to understand the potential safety and virucidal properties of Betadine® antiseptic products in which povidone iodine forms an active ingredient. Companies in the povidone iodine market are increasing their efficacy in in vitro and in vivo studies to examine the effectiveness of povidone iodine against the virus causing COVID-19.
The concept of skin sterilization is gaining increased importance amidst the ongoing COVID-19 pandemic. Moreover, the revenue of skin sterilization application segment of the povidone iodine market is projected for aggressive growth during the forecast period. Thus, betadine antiseptic products hold promising potentials in reducing the number of microorganisms on the skin.
Excellent Bactericidal Activity of Povidone Iodine Aids in Treatment of MRSA Infections
Nasal decolonization is a common practice to control and prevent the spread of methicillin-resistant staphylococcus aureus (MRSA) infections.
Strong expertise with attention to detail makes our market research reports stand apart. Download PDF Brochure –
As such, intranasal mupirocin ointment and chlorhexidine wash are considered as the gold standard for the treatment of MRSA infections.
Request for Covid-19 Impact Analysis on Povidone iodine market:
However, resistance and failure associated with these treatment strategies are encouraging the use of povidone iodine (PVP-I) as an alternative decolonization agent for the treatment of the MRSA infection. Hence, companies in the povidone iodine market are boosting their production capabilities to increase the availability of PVP-I, where the market is estimated to cross the volume of ~16,000 tons by the end of 2030.
Buy our Premium Research Report on Povidone iodine market@
Povidone iodine holds potential in the treatment of MRSA infections, owing to its rapid and superior bactericidal activity as compared to intranasal mupirocin ointment and chlorhexidine wash. Companies in the povidone iodine market are increasing the applicability of PVP-I in reducing the incidences of surgical site infections (SSI) during orthopedic surgeries.
More Trending Reports by Transparency Market Research –
Antiseptic formulations are being highly publicized as effective vaginal antiseptic solutions. Among cetrimide and metronidazole, even povidone iodine is found to significantly reduce the risk of endometritis in women after childbirth. As such, the povidone iodine market is estimated to reach a value of ~US$ 256.7 Bn by the end of 2030. This is evident since povidone iodine products are pervasively replacing most saline solutions.
Povidone iodine 1% holds high probability of being one of the most effective solution for the prevention of endometritis. On the other hand, companies in the povidone iodine market are increasing the applicability of PVP-I in order to prevent secondary outcomes of postoperative wound infection and fever associated with endometritis. Companies are tapping into incremental opportunities with the help of povidone iodine in applications such as presurgical vaginal irrigation to prevent postoperative wound infections and fever in women.
Companies in the povidone iodine market are broadening their revenue streams by increasing the production of topical drug formulations used for wound healing and infection treatment. This explains why the povidone iodine market is slated to register a favorable CAGR of ~5% during the forecast period. Manufacturers are increasing their efficacy to conduct in vitro and in vivo investigations of povidone iodine liposome hydrogel for topical wound treatment applications.
There is a growing demand for a combination of anti-infectious therapy and a healing-promoting moisturization in topical drug formulations. Hence, manufacturers are increasing their production capabilities for povidone iodine liposome hydrogel that allows both antiseptic and moist treatment. Pharmaceutical formulations typically involve a complex of PVP-I (3%) and phosphatidylcholine in a hydrogel. Manufacturers are investigating a direct interaction of the povidone iodine liposomes with microorganisms by attaching to the cell surface to evaluate the antimicrobial activity.
Povidone iodine is proving as a game changer in infection treatment. However, alternative compounds such as molecular iodine (I2) products pose as a threat to the sales of povidone iodine in dentistry. For instance, ioTech International- a specialist in molecular iodine R&D, has revealed its patented stable aqueous formulation of I2, which contains several parts per million (ppm) as compared to povidone iodine. Hence, companies in the povidone iodine market are focusing on skin sterilization applications in order to create revenue streams.
On the other hand, manufacturers in the povidone iodine market are developing improved formulations of eye drops that help in reducing conjunctival bacteria load for patients undergoing anti-VEGF (Vascular Endothelial Growth Factor) intravitreal injection.
An alarmingly high rate of periodontal diseases among individuals worldwide has fueled the demand for povidone iodine impregnated dental floss. This is a prominent trend in Asian countries, which explains why the revenue of Asia Pacific is expected to exponentially grow in the povidone iodine market. Since periodontal diseases result in tooth loss and destruction of tooth-supporting structures, consumers are opting for povidone iodine induced dental floss to limit the progression of diseases. As such, the International Association for Dental Research is increasing awareness for antimicrobial agents such as povidone iodine for the prevention of periodontal diseases in individuals.
Advantageous attributes of low cost povidone iodine such as low systemic toxicity and easy application are playing a vital role in the removal of tooth-surface dental-plaque biofilms. As such, there is a growing demand for dental devices containing antimicrobial agents for the management of bacterial pathogens.
Analysts’ Viewpoint
Gargling with both povidone-iodine and chlorinated tap water is acquiring increased importance amidst the COVID-19 outbreak to prevent the risks of upper respiratory tract infections. Manufacturers in the povidone iodine market are improving their designing and formulation capabilities to tap revenue opportunities in dental devices and PVP-I induced dental floss products. Since chlorhexidine-alcohol (CA) is an alternative to povidone iodine before elective CS (cesarean section), companies should increase their production capabilities, as low cost of PVP-I offsets the advantages of CA. PVP-I liposome hydrogels are being highly publicized for use in wound healing applications, owing to its advantage of enhanced epithelization.
Povidone Iodine Market: Overview
Povidone Iodine Market: Key Drivers and Restraints
Povidone Iodine Market: Key Region
Povidone Iodine Market: Prominent Application Segment
Povidone Iodine Market: Key Developments
Povidone Iodine Market: Competition Landscape
Chemicals & Materials Industry battles Tangible Impact of Economic and Cultural changes, Stay Updated on the Latest Trends in Chemicals & Materials Market @ https://www.transparencymarketresearch.com/chemical-market-reports-2.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
The COVID-19 (coronavirus) continues to register new cases worldwide. Hence, companies in the povidone iodine market are increasing their R&D efforts to evaluate the efficacy of PVP-I against the novel coronavirus. For instance, global leader of consumer health products, Avrio Health L.P., has initiated a program to understand the potential safety and virucidal properties of Betadine® antiseptic products in which povidone iodine forms an active ingredient. Companies in the povidone iodine market are increasing their efficacy in in vitro and in vivo studies to examine the effectiveness of povidone iodine against the virus causing COVID-19.
The concept of skin sterilization is gaining increased importance amidst the ongoing COVID-19 pandemic. Moreover, the revenue of skin sterilization application segment of the povidone iodine market is projected for aggressive growth during the forecast period. Thus, betadine antiseptic products hold promising potentials in reducing the number of microorganisms on the skin.
Excellent Bactericidal Activity of Povidone Iodine Aids in Treatment of MRSA Infections
Nasal decolonization is a common practice to control and prevent the spread of methicillin-resistant staphylococcus aureus (MRSA) infections.
Strong expertise with attention to detail makes our market research reports stand apart. Download PDF Brochure –
As such, intranasal mupirocin ointment and chlorhexidine wash are considered as the gold standard for the treatment of MRSA infections.
Request for Covid-19 Impact Analysis on Povidone iodine market:
However, resistance and failure associated with these treatment strategies are encouraging the use of povidone iodine (PVP-I) as an alternative decolonization agent for the treatment of the MRSA infection. Hence, companies in the povidone iodine market are boosting their production capabilities to increase the availability of PVP-I, where the market is estimated to cross the volume of ~16,000 tons by the end of 2030.
Buy our Premium Research Report on Povidone iodine market@
Povidone iodine holds potential in the treatment of MRSA infections, owing to its rapid and superior bactericidal activity as compared to intranasal mupirocin ointment and chlorhexidine wash. Companies in the povidone iodine market are increasing the applicability of PVP-I in reducing the incidences of surgical site infections (SSI) during orthopedic surgeries.
More Trending Reports by Transparency Market Research –
Antiseptic formulations are being highly publicized as effective vaginal antiseptic solutions. Among cetrimide and metronidazole, even povidone iodine is found to significantly reduce the risk of endometritis in women after childbirth. As such, the povidone iodine market is estimated to reach a value of ~US$ 256.7 Bn by the end of 2030. This is evident since povidone iodine products are pervasively replacing most saline solutions.
Povidone iodine 1% holds high probability of being one of the most effective solution for the prevention of endometritis. On the other hand, companies in the povidone iodine market are increasing the applicability of PVP-I in order to prevent secondary outcomes of postoperative wound infection and fever associated with endometritis. Companies are tapping into incremental opportunities with the help of povidone iodine in applications such as presurgical vaginal irrigation to prevent postoperative wound infections and fever in women.
Companies in the povidone iodine market are broadening their revenue streams by increasing the production of topical drug formulations used for wound healing and infection treatment. This explains why the povidone iodine market is slated to register a favorable CAGR of ~5% during the forecast period. Manufacturers are increasing their efficacy to conduct in vitro and in vivo investigations of povidone iodine liposome hydrogel for topical wound treatment applications.
There is a growing demand for a combination of anti-infectious therapy and a healing-promoting moisturization in topical drug formulations. Hence, manufacturers are increasing their production capabilities for povidone iodine liposome hydrogel that allows both antiseptic and moist treatment. Pharmaceutical formulations typically involve a complex of PVP-I (3%) and phosphatidylcholine in a hydrogel. Manufacturers are investigating a direct interaction of the povidone iodine liposomes with microorganisms by attaching to the cell surface to evaluate the antimicrobial activity.
Povidone iodine is proving as a game changer in infection treatment. However, alternative compounds such as molecular iodine (I2) products pose as a threat to the sales of povidone iodine in dentistry. For instance, ioTech International- a specialist in molecular iodine R&D, has revealed its patented stable aqueous formulation of I2, which contains several parts per million (ppm) as compared to povidone iodine. Hence, companies in the povidone iodine market are focusing on skin sterilization applications in order to create revenue streams.
On the other hand, manufacturers in the povidone iodine market are developing improved formulations of eye drops that help in reducing conjunctival bacteria load for patients undergoing anti-VEGF (Vascular Endothelial Growth Factor) intravitreal injection.
An alarmingly high rate of periodontal diseases among individuals worldwide has fueled the demand for povidone iodine impregnated dental floss. This is a prominent trend in Asian countries, which explains why the revenue of Asia Pacific is expected to exponentially grow in the povidone iodine market. Since periodontal diseases result in tooth loss and destruction of tooth-supporting structures, consumers are opting for povidone iodine induced dental floss to limit the progression of diseases. As such, the International Association for Dental Research is increasing awareness for antimicrobial agents such as povidone iodine for the prevention of periodontal diseases in individuals.
Advantageous attributes of low cost povidone iodine such as low systemic toxicity and easy application are playing a vital role in the removal of tooth-surface dental-plaque biofilms. As such, there is a growing demand for dental devices containing antimicrobial agents for the management of bacterial pathogens.
Analysts’ Viewpoint
Gargling with both povidone-iodine and chlorinated tap water is acquiring increased importance amidst the COVID-19 outbreak to prevent the risks of upper respiratory tract infections. Manufacturers in the povidone iodine market are improving their designing and formulation capabilities to tap revenue opportunities in dental devices and PVP-I induced dental floss products. Since chlorhexidine-alcohol (CA) is an alternative to povidone iodine before elective CS (cesarean section), companies should increase their production capabilities, as low cost of PVP-I offsets the advantages of CA. PVP-I liposome hydrogels are being highly publicized for use in wound healing applications, owing to its advantage of enhanced epithelization.
Povidone Iodine Market: Overview
Povidone Iodine Market: Key Drivers and Restraints
Povidone Iodine Market: Key Region
Povidone Iodine Market: Prominent Application Segment
Povidone Iodine Market: Key Developments
Povidone Iodine Market: Competition Landscape
Chemicals & Materials Industry battles Tangible Impact of Economic and Cultural changes, Stay Updated on the Latest Trends in Chemicals & Materials Market @ https://www.transparencymarketresearch.com/chemical-market-reports-2.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Explore more articles in the Research Reports category
